Efficacy and Safety of Laser‐Assisted Combination Chemotherapy: An Explorative Imaging‐Guided Treatment With 5‐Fluorouracil and Cisplatin for Basal Cell Carcinoma

Lasers in Surgery and Medicine ◽

10.1002/lsm.23323 ◽

2020 ◽

Author(s):

Emily Wenande ◽

Kristoffer Hendel ◽

Mette Mogensen ◽

Charlotte Bagger ◽

Nina L. Mårtensson ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Combination Chemotherapy ◽

Efficacy And Safety

Download Full-text

Efficacy and safety of laser‐assisted combination chemotherapy: A follow‐up study of treatment with 5‐fluorouracil and cisplatin for basal cell carcinoma

Lasers in Surgery and Medicine ◽

10.1002/lsm.23497 ◽

2021 ◽

Author(s):

Gabriella Fredman ◽

Emily Wenande ◽

Kristoffer Hendel ◽

Katrine Togsverd‐Bo ◽

Merete Haedersdal

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Combination Chemotherapy ◽

Efficacy And Safety ◽

Follow Up Study

Download Full-text

Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.14542 ◽

2017 ◽

Vol 32 (3) ◽

pp. 372-381 ◽

Cited By ~ 54

Author(s):

J.T. Lear ◽

M.R. Migden ◽

K.D. Lewis ◽

A.L.S. Chang ◽

A. Guminski ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Phase 2 ◽

Efficacy And Safety ◽

Term Efficacy ◽

Metastatic Basal Cell Carcinoma ◽

Randomized Phase 2

Download Full-text

Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial

Clinical Cosmetic and Investigational Dermatology ◽

10.2147/ccid.s233097 ◽

2020 ◽

Vol Volume 13 ◽

pp. 117-121 ◽

Cited By ~ 3

Author(s):

John T Lear ◽

Axel Hauschild ◽

Eggert Stockfleth ◽

Nicholas Squittieri ◽

Nicole Basset-Seguin ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Randomized Trial ◽

Cell Carcinoma ◽

Basal Cell ◽

Adult Patients ◽

Phase 2 ◽

Efficacy And Safety ◽

Gorlin Syndrome ◽

Double Blind

Download Full-text

Letter to the editor submitted in response to “efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a Meta-analysis of randomised controlled trial”

Journal of Dermatological Treatment ◽

10.1080/09546634.2019.1659478 ◽

2019 ◽

pp. 1-1 ◽

Cited By ~ 1

Author(s):

Emma Axon ◽

Douglas J. Grindlay

Keyword(s):

Randomised Controlled Trial ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Controlled Trial ◽

Meta Analysis ◽

Efficacy And Safety ◽

Letter To The Editor ◽

Randomised Controlled

Download Full-text

Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial

Journal of Dermatological Treatment ◽

10.1080/09546634.2019.1638883 ◽

2019 ◽

Vol 31 (8) ◽

pp. 831-838 ◽

Cited By ~ 2

Author(s):

Hong-Xia Jia ◽

Yan-Ling He

Keyword(s):

Randomized Controlled Trial ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Controlled Trial ◽

Meta Analysis ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities

Dermatologic Therapy ◽

10.1111/dth.13108 ◽

2019 ◽

Vol 32 (6) ◽

Cited By ~ 4

Author(s):

Giulia Spallone ◽

Pietro Sollena ◽

Alessandra Ventura ◽

Maria C. Fargnoli ◽

Carlota Gutierrez ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717950275.793505944 ◽

2015 ◽

Author(s):

John Carucci

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717950275.793455534 ◽

2012 ◽

Author(s):

Alexander Eggermont

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

42-month follow-up of sonidegib efficacy and safety in advanced basal cell carcinoma: Final analysis from BOLT.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.9551 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 9551-9551 ◽

Cited By ~ 2

Author(s):

Michael Robert Migden ◽

Karl D. Lewis

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Final Analysis ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

Metastatic basal cell carcinoma with a novel truncation mutation in PTCH1 successfully treated with combination chemotherapy containing cisplatin and doxorubicin

The Journal of Dermatology ◽

10.1111/1346-8138.15751 ◽

2021 ◽

Author(s):

Soichiro Watanabe ◽

Yohei Iwata ◽

Kazumitsu Sugiura

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Combination Chemotherapy ◽

Truncation Mutation ◽

Metastatic Basal Cell Carcinoma

Download Full-text